India is facing a major health crisis, with rising obesity rates across all age groups, leading to increased early mortality ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

Rare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

In conclusion, the Glucagon-like Peptide-1 agonists market is poised for significant growth through 2034, driven by the ...

The effect of glucagon-like peptide 1 receptor agonists on patients with joint infections was a popular topic at the American ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...